EpiVario files Form D for $500,000 debt offering
The Philadelphia pharmaceutical company has sold $185,000 of a planned $500,000 note offering to nine investors as of October 13, 2026.
SEC filing
Latest
1 story
Sign inSign in1 story
The Philadelphia pharmaceutical company has sold $185,000 of a planned $500,000 note offering to nine investors as of October 13, 2026.
SEC filing